or Try an Advanced Search...

    Neuropathic Pain Stocks List

    Symbol Grade Name % Change
    ELYM B Eliem Therapeutics, Inc 17.40
    NKTR B Nektar Therapeutics 0.00
    XENE D Xenon Pharmaceuticals Inc. 1.00
    BIIB D Biogen Idec Inc. 3.18
    CHRO F Chromocell Therapeutics Corporation 6.67
    ASRT F Assertio Therapeutics, Inc. 5.49
    BLRX F BioLineRx Ltd. 6.31
    RVNC F Revance Therapeutics, Inc. 3.34
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pain Biotechnology Biopharmaceutical Acute Pain Analgesics Chemical Compounds Chronic Pain Clinical Development Drugs Erythromelalgia Immunology Migraine Opioids Organic Compounds Peripheral Neuropathy Pharmaceutical Pharmacology Postherpetic Neuralgia Acne Acute Myeloid Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Neuropathic Pain stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 8.34
    PBE D PowerShares Dynamic Biotech & Genome 7.03
    BIS B ProShares UltraShort Nasdaq Biotechnology 6.6
    DIP A BTD Capital Fund 4.41
    BBH D Market Vectors Biotech ETF 4.31
    View all Neuropathic Pain ETFs...
    Compare ETFs
    Compare DIP to BBH Compare IBRN to DIP Compare PBE to BIS

        Neuropathic Pain Stocks Recent News

        Date Stock Title
        Apr 26 BIIB The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
        Apr 26 BIIB Decoding Biogen Inc (BIIB): A Strategic SWOT Insight
        Apr 25 BIIB Biogen Receives Positive CHMP Opinion for TOFIDENCE™ (tocilizumab), a Biosimilar Referencing ROACTEMRA®
        Apr 25 BIIB Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
        Apr 25 BIIB Biogen Inc. (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript
        Apr 25 BIIB Shareholders 30% loss in Biogen (NASDAQ:BIIB) partly attributable to the company's decline in earnings over past year
        Apr 25 ASRT Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
        Apr 25 BIIB For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
        Apr 25 BIIB Q1 2024 Biogen Inc Earnings Call
        Apr 24 BIIB Why Biogen Stock Leaped Nearly 5% Higher Today
        Apr 24 BIIB Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings
        Apr 24 BIIB Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
        Apr 24 BIIB Biogen (BIIB) Q1 2024 Earnings Call Transcript
        Apr 24 BIIB Biogen: Don’t expect any big acquisitions this year
        Apr 24 BIIB Biogen Inc. (BIIB) Q1 2024 Earnings Call Transcript
        Apr 24 BIIB Biogen Stock Rises After Earnings, Jump in Sales of Alzheimer’s Drug
        Apr 24 BIIB Biogen stock rises on Q1 results, Alzheimer's drug sales
        Apr 24 BIIB Biogen Affirms Guidance After Mixed First Quarter
        Apr 24 BIIB Alzheimer’s Drug Leqembi Sees Sales Pickup, Boosting Biogen Stock
        Apr 24 BIIB Biogen Beats Estimates as Alzheimer’s Drug Gains Traction
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pain Biotechnology Biopharmaceutical Acute Pain Analgesics Chemical Compounds Chronic Pain Clinical Development Drugs Erythromelalgia Immunology Migraine Opioids Organic Compounds Peripheral Neuropathy Pharmaceutical Pharmacology Postherpetic Neuralgia Acne Acute Myeloid Leukemia
        Neuropathic Pain

        Neuropathic pain is a type of chronic pain that is caused by damage or disease affecting the somatosensory nervous system. It is often described as a shooting, burning, or tingling sensation. Neuropathic pain can be caused by a variety of conditions, including diabetes, multiple sclerosis, shingles, and spinal cord injury.

        Browse All Tags